Elevated levels of ATAD3A have been found in lung adenocarcinomas, prostate cancer, head and neck cancer, gliomas, uterine cervical cancer, and breast cancer [18,35,39,40,41,42]. This evidence concerns the gene ATAD3A and prostate carcinoma.